Tennessee Oncology, a nationally recognized independent oncology practice with 35 clinics across Tennessee and Northwest Georgia, announced today new roles for three physician executive leaders.
Johnetta Blakely, MD, MS, MMHC
Johnetta Blakely, MD, MS, MMHC; Casey Chollet Lipscomb, MD, and Edward R. "Ted" Arrowsmith, MD, MPH, have been promoted to Executive Vice President of Quality and Clinical Operations, Physician Services, and Therapeutics,
Casey Chollet Lipscomb MD
respectively. All 3 physicians are currently on Tennessee Oncology’s board of directors and are practicing physicians. Blakely practices in Cookeville, Chollet Lipscomb practices in Nashville, and Arrowsmith treats patients in Chattanooga.
Edward R. "Ted" Arrowsmith | All Images: Tennessee Oncology
“Each of these oncologists are world-class physicians and leaders who will help take Tennessee Oncology to the next level,” said Natalie Dickson, MD, president and chief strategy officer. “I am excited to work alongside my colleagues to build on Tennessee Oncology’s proud history and continue bringing the highest quality of cancer care and innovative therapies to Tennessee patients. Caring for cancer patients is indeed a privilege, and I’m looking forward to contributions of each of my colleagues.”
Blakely attended the University of Tennessee’s medical school. She completed her fellowship in hematology/oncology at MD Anderson Cancer Center, holds a master’s degree in clinical research from MD Anderson as well as a master’s degree in healthcare management from Vanderbilt. Chollet Lipscomb attended medical school at University of Tennessee, conducted her residency at Loyola University Medical Center in Chicago, and was an attending at Duke University prior to joining Tennessee Oncology. Arrowsmith’s medical degree and fellowship are both from Vanderbilt University. He is also the head of pathway development at OneOncology, the fastest growing national platform for independent oncology practices.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More